Why Growth Is Coming to Abbott Laboratories Stock

Abbott Laboratories (NYSE: ABT  ) markets everything from Similac baby formula to cataract surgery equipment and its restructuring itself in order to spark revenue growth. 

Abbott is a long-standing member of the S&P 500 dividend aristocrats, a collection of companies with a proud history of dividend increases, so investors are right to wonder if sluggish sales tied to a recall last fall are ready to rebound.

Source: Abbott Labs

In the following slideshow, I include the most important takeaways from Abbott's second-quarter results and highlight the key reasons Abbott may find the second half of this year is better than the first.

Even Abbott may struggle to outperform these top dividend stocks over the next decade
The smartest investors know that dividend stocks simply crush their non-dividend paying counterparts over the long term. That's beyond dispute. They also know that a well-constructed dividend portfolio creates wealth steadily, while still allowing you to sleep like a baby. Knowing how valuable such a portfolio might be, our top analysts put together a report on a group of high-yielding stocks that should be in any income investor's portfolio. To see our free report on these stocks, just click here now.

Read/Post Comments (1) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On July 18, 2014, at 6:41 PM, PEStudent wrote:

    Nice and Informative. Thanks, Todd

    I would point out the line in the slide show that says "Margin stabilizing and improving" is one of Abbott's top concerns since spinning off AbbVie.

    Abbott's margins in every division were much less than competitors and raising them to competitive levels has been a major goal which is being achieved.

Add your comment.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 3032757, ~/Articles/ArticleHandler.aspx, 9/5/2015 2:11:19 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Todd Campbell

Todd has been helping buy side portfolio managers as an independent researcher for over a decade. In 2003, Todd founded E.B. Capital Markets, LLC, a research firm providing action oriented ideas to professional investors. Todd has provided insight to a variety of publications, including SmartMoney, Barron's, and CNN/fn.

Today's Market

updated 4 hours ago Sponsored by:
DOW 16,102.38 -272.38 -1.66%
S&P 500 1,921.22 -29.91 -1.53%
NASD 4,683.92 -49.58 -1.05%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

9/4/2015 4:00 PM
ABT $43.07 Down -1.07 -2.42%
Abbott Laboratorie… CAPS Rating: *****